SCHEMBL328377

SCHEMBL328377

Cc1cc(O)cc(C)c1Cc1ccc(O)c(C(C)C)c1

nearest known ligand 0.67

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
THRB P10828 19/20 0.67
THRA P10827 18/20 0.67
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25773018 0.90 THRB (0.71) THRBTHRAESR1ESR2
SCHEMBL25983465 0.89 THRB (0.53) THRBTHRAESR1ESR2
SCHEMBL4963467 0.88 THRB (0.64) THRBTHRAESR1ESR2
SCHEMBL27703134 0.88 THRB (0.64) THRBTHRAESR1ESR2
SCHEMBL1457668 0.88 THRB (0.67) THRBTHRAESR1ESR2
SCHEMBL27702889 0.88 THRB (0.64) THRBTHRAESR1ESR2
SCHEMBL12824810 0.86 THRB (0.67) THRBTHRAESR1ESR2
SCHEMBL7369671 0.86 THRA (0.54) THRBTHRA
SCHEMBL10064689 0.85 THRB (0.69) THRBTHRA
SCHEMBL4196757 0.85 THRB (0.61) THRBTHRAESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119431265-A Compound as thyroid hormone receptor agonist 南京瑞捷医药科技有限公司 2025-02-14 CN disclosed
CN-113474335-B Compounds and their use as thyroid hormone receptor agonists 南京瑞捷医药科技有限公司 2024-12-03 CN disclosed
CN-106414718-A SC-beta cells and compositions and methods for producing the same 哈佛学院校长同事会 2017-02-15 CN disclosed
CN-105579577-A SC-beta cells and compositions and methods for producing the same HARVARD COLLEGE 2016-05-11 CN disclosed
CN-104940126-A Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders OTONOMY INC 2015-09-30 CN disclosed
CN-102105133-B Controlled release otic structure modulating and innate immune system modulating compositions and methods of treating otic disorders OTONOMY INC 2015-06-17 CN disclosed
CN-104491864-A Controlled Release Antimicrobial Compositions And Methods For The Treatment Of Otic Disorders OTONOMY INC 2015-04-08 CN disclosed
CN-102014957-B Otic formulations for the treatment of otic diseases and conditions OTONOMY INC 2014-12-10 CN disclosed
EP-2567959-A1 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors SANOFI (FR) 2013-03-13 EP disclosed
EP-2428516-A1 Novel phosphorus-containing thyromimetics Metabasis Therapeutics, Inc. (US) 2012-03-14 EP disclosed
EP-1891080-A2 NOVEL PHOSPHORUS-CONTAINING THYROMIMETICS Metabasis Therapeutics, Inc. (US) 2008-02-27 EP disclosed
EP-1890768-A2 NOVEL PHOSPHINIC ACID-CONTAINING THYROMIMETICS Metabasis Therapeutics, Inc. (US) 2008-02-27 EP disclosed
CN-1882327-A Novel phosphorus-containing thyromimetics METABASIS THERAPEUTICS INC (US) 2006-12-20 CN disclosed
WO-2006128056-A2 NOVEL PHOSPHINIC ACID-CONTAINING THYROMIMETICS METABASIS THERAPEUTICS, INC. (US) 2006-11-30 WO disclosed
WO-2006128055-A2 NOVEL PHOSPHORUS-CONTAINING THYROMIMETICS METABASIS THERAPEUTICS, INC. (US) 2006-11-30 WO disclosed
EP-0991618-B1 SELECTIVE THYROID HORMONE ANALOGS UNIV CALIFORNIA (US) 2003-11-12 EP disclosed
EP-0991618-A4 SELECTIVE THYROID HORMONE ANALOGS UNIV CALIFORNIA (US) 2000-09-27 EP disclosed
EP-0991618-A1 SELECTIVE THYROID HORMONE ANALOGS The Regents of the University of California (US) 2000-04-12 EP disclosed
US-5883294-A THYROID HORMONE AGONIST THE REGEANTS OF THE UNIVERSITY OF CALIFORNIA (US) 1999-03-16 US disclosed
WO-1998057919-A1 SELECTIVE THYROID HORMONE ANALOGS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-12-23 WO disclosed